摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-hydroxyacetoxy)propionic acid | 136532-17-7

中文名称
——
中文别名
——
英文名称
2-(2-hydroxyacetoxy)propionic acid
英文别名
2-(2-Hydroxyacetyl)oxypropanoic acid
2-(2-hydroxyacetoxy)propionic acid化学式
CAS
136532-17-7
化学式
C5H8O5
mdl
MFCD19231477
分子量
148.116
InChiKey
HKVBZVITUCIVRZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    83.8
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(2-hydroxyacetoxy)propionic acid三聚氯氰三乙胺 作用下, 以 丙酮 为溶剂, 以72%的产率得到3-甲基-1,4-二噁烷-2,5-二酮
    参考文献:
    名称:
    功能化双内酯作为合成聚(α-羟基)酸单体的通用途径
    摘要:
    描述了在结构上类似于丙交酯的功能化六元双内酯的合成途径。通过使用正交保护基团,通过氰尿酰氯介导的相应线性α-羟基酸二聚体的环化,以直接的方式合成官能化双内酯。三种不同的双内酯 - 甲基乙交酯、苄氧基甲基乙交酯和 2-苄氧基甲基-5-甲基乙交酯 - 通过相同的程序合成证明了该路线的多功能性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
    DOI:
    10.1002/ejoc.200300181
  • 作为产物:
    描述:
    benzyl 2-[2-(tert-butyldimethylsilanyloxy)acetoxy]propionate 在 palladium on activated charcoal 四丁基氟化铵氢气溶剂黄146 作用下, 以 乙醇乙酸乙酯 为溶剂, 反应 3.0h, 生成 2-(2-hydroxyacetoxy)propionic acid
    参考文献:
    名称:
    功能化双内酯作为合成聚(α-羟基)酸单体的通用途径
    摘要:
    描述了在结构上类似于丙交酯的功能化六元双内酯的合成途径。通过使用正交保护基团,通过氰尿酰氯介导的相应线性α-羟基酸二聚体的环化,以直接的方式合成官能化双内酯。三种不同的双内酯 - 甲基乙交酯、苄氧基甲基乙交酯和 2-苄氧基甲基-5-甲基乙交酯 - 通过相同的程序合成证明了该路线的多功能性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
    DOI:
    10.1002/ejoc.200300181
  • 作为试剂:
    参考文献:
    名称:
    pH-sensitive nanoparticles for oral insulin delivery
    摘要:
    本发明揭示了由pH敏感聚合物、疏水材料、内部稳定剂、外部稳定剂和胰岛素药物组成的pH敏感纳米颗粒。本发明还包括一种制备pH敏感纳米颗粒的方法,特别是多重乳液溶剂蒸发法。本发明的pH敏感纳米颗粒具有100-300纳米的粒径和良好的pH敏感性能。在链脲佐菌素(STZ)诱导的糖尿病大鼠中观察到明显的血糖水平下降,并且在口服胰岛素负载的pH敏感纳米颗粒后,胰岛素的生物利用度超过10%。
    公开号:
    US08859004B2
点击查看最新优质反应信息

文献信息

  • Composite Materials Based On Polysilicic Acid And Method For The Production Thereof
    申请人:Teller Marianne
    公开号:US20070196419A1
    公开(公告)日:2007-08-23
    The invention relates to composite materials based on polysilicic acid, said materials containing novel compositions which have improved material properties and can be in the form of dispersions, pastes, powders, granulated materials, layers or compact moulded bodies. The aim of the invention is to produce composite materials based on polysilicic acid with improved mechanical properties. To this end, the composite materials contain polysilicic acid, between 0.01 and 20 mass % of an organic polymer, more than 15 mass % of at least one calcium phosphate phase, and optionally a use-specific additive. The material produced according to the invention can be implanted or injected. The composition of the composite material with the resulting properties enables the composite material to be used for bone substitution and/or bone regeneration in both human medicine and animal medicine. The inventive material can also be used to heal wounds.
    本发明涉及基于多硅酸的复合材料,该材料含有具有改进材料性质的新型组分,可以呈现为分散体、浆糊、粉末、颗粒材料、层或紧凑成型体。本发明的目的是生产基于多硅酸的复合材料,具有改进的机械性能。为此,复合材料含有多硅酸、0.01至20质量%的有机聚合物、超过15质量%的至少一种磷酸钙相,以及可选的用途特定添加剂。根据本发明制备的材料可以植入或注射。复合材料的组成和所得性能使得该复合材料可用于人类医学和动物医学中的骨替代和/或骨再生。本发明材料还可用于愈合伤口。
  • pH-SENSITIVE NANOPARTICLES FOR ORAL INSULIN DELIVERY
    申请人:ZHANG Lijuan
    公开号:US20130034589A1
    公开(公告)日:2013-02-07
    The present invention discloses the pH-sensitive nanoparticles composed of pH-sensitive polymer, hydrophobic material, internal stabilizer, external stabilizer content and insulin drug. The present invention also includes a method for preparation of pH-sensitive nanoparticles, in particular, a multiple emulsions solvent evaporation method. The pH-sensitive nanoparticles of the present invention show good pH-sensitive property with 100-300 nanometer particle size. Significant decrease in blood glucose level is observed in streptozotocin (STZ)-induced diabetic rats and the bioavailability of insulin is more than 10% after oral administration of the insulin-loaded pH-sensitive nanoparticles.
    本发明揭示了由pH敏感聚合物、疏水材料、内部稳定剂、外部稳定剂和胰岛素药物组成的pH敏感纳米粒子。本发明还包括一种制备pH敏感纳米粒子的方法,特别是一种多重乳液溶剂蒸发法。本发明的pH敏感纳米粒子具有100-300纳米的粒径和良好的pH敏感性能。在链脲佐菌素(STZ)诱导的糖尿病大鼠中观察到明显的血糖水平下降,并且口服胰岛素负载的pH敏感纳米粒子的生物利用度超过10%。
  • New Insights into Poly(lactic-<i>co</i>-glycolic acid) Microstructure: Using Repeating Sequence Copolymers To Decipher Complex NMR and Thermal Behavior
    作者:Ryan M. Stayshich、Tara Y. Meyer
    DOI:10.1021/ja102670n
    日期:2010.8.11
    Sequence, which Nature uses to spectacular advantage, has not been fully exploited in synthetic copolymers. To investigate the effect of sequence and stereosequence on the physical properties of copolymers, a family of complex isotactic, syndiotactic, and atactic repeating sequence poly(lactic-co-glycolic acid) copolymers (RSC PLGAs) were prepared and their NMR and thermal behavior was studied. The unique suitability of polymers prepared from the bioassimilable lactic and glycolic acid monomers for biomedical applications makes them ideal candidates for this type of sequence engineering. Polymers with repeating units of LG, GLG and LLG (L = lactic, G = glycolic) with controlled and varied tacticities were synthesized by assembly of sequence-specific, stereopure dimeric, trimeric, and hexameric segmer units. Specifically labeled deuterated lactic and glycolic acid segmers were likewise prepared and polymerized. Molecular weights for the copolymers were in the range M-n = 12-40 kDa by size exclusion chromatography in THF. Although the effects of sequence-influenced solution conformation were visible in all resonances of the H-1 and C-13 NMR spectra, the diastereotopic methylene resonances in the H-1 NMR (CDCl3) for the glycolic units of the copolymers proved most sensitive. An octad level of resolution, which corresponds to an astounding 31-atom distance between the most separated stereocenters, was observed in some mixed sequence polymers. Importantly, the level of sensitivity of a particular NMR resonance to small differences in sequence was found to depend on the sequence itself. Thermal properties were also correlated with sequence.
  • A Versatile Route to Functionalized Dilactones as Monomers for the Synthesis of Poly(α-hydroxy) Acids
    作者:Mark Leemhuis、Jan Hein van Steenis、Michelle J. van Uxem、Cornelus F. van Nostrum、Wim E. Hennink
    DOI:10.1002/ejoc.200300181
    日期:2003.9
    A synthetic pathway to functionalized six-membered dilactones structurally analogous to lactide is described. Through the use of orthogonal protecting groups, the synthesis of functionalized dilactones was performed in a straightforward way by cyanuric chloride-mediated cyclization of the corresponding linear α-hydroxy acid dimers. The synthesis of three different dilactones − methylglycolide, ben
    描述了在结构上类似于丙交酯的功能化六元双内酯的合成途径。通过使用正交保护基团,通过氰尿酰氯介导的相应线性α-羟基酸二聚体的环化,以直接的方式合成官能化双内酯。三种不同的双内酯 - 甲基乙交酯、苄氧基甲基乙交酯和 2-苄氧基甲基-5-甲基乙交酯 - 通过相同的程序合成证明了该路线的多功能性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
  • pH-sensitive nanoparticles for oral insulin delivery
    申请人:Zhang Lijuan
    公开号:US08859004B2
    公开(公告)日:2014-10-14
    The present invention discloses the pH-sensitive nanoparticles composed of pH-sensitive polymer, hydrophobic material, internal stabilizer, external stabilizer content and insulin drug. The present invention also includes a method for preparation of pH-sensitive nanoparticles, in particular, a multiple emulsions solvent evaporation method. The pH-sensitive nanoparticles of the present invention show good pH-sensitive property with 100-300 nanometer particle size. Significant decrease in blood glucose level is observed in streptozotocin (STZ)-induced diabetic rats and the bioavailability of insulin is more than 10% after oral administration of the insulin-loaded pH-sensitive nanoparticles.
    本发明揭示了由pH敏感聚合物、疏水材料、内部稳定剂、外部稳定剂和胰岛素药物组成的pH敏感纳米颗粒。本发明还包括一种制备pH敏感纳米颗粒的方法,特别是多重乳液溶剂蒸发法。本发明的pH敏感纳米颗粒具有100-300纳米的粒径和良好的pH敏感性能。在链脲佐菌素(STZ)诱导的糖尿病大鼠中观察到明显的血糖水平下降,并且在口服胰岛素负载的pH敏感纳米颗粒后,胰岛素的生物利用度超过10%。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物